Nitric Oxide-cGMP and Prostacyclin-cAMP Pathways in Patients with Type II Diabetes and Different Types of Retinopathy

Publisher： Karger

E-ISSN： 1424-8840|32|1|25-32

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.1, 2002-05, pp. : 25-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitric Oxide, Peroxynitrite and cGMP in Atherosclerosis-Induced Hypertension in Rabbits: Beneficial Effects of Cicletanine

By  

Journal of Vascular Research, Vol. 38, Iss. 1, 2001-02 ,pp. : 39-46

Karger

Access to resources Recommend Favorite

Translational promise for NO pathway

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 6, 2015-03 ,pp. : 1397-1414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

By Miller Michael   Dobs Adrian   Yuan Zhong   Battisti Wendy P.   Borisute Hannah   Palmisano Joanne  

Current Medical Research and Opinion, Vol. 20, Iss. 7, 2004-07 ,pp. : 1087-1094

Informa Healthcare

Access to resources Recommend Favorite

Cyclic Nucleotide-Dependent Protein Kinases: Intracellular Receptors for cAMP and cGMP Action

By Francis Sharron H.   Corbin Jackie D.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 36, Iss. 4, 1999-08 ,pp. : 275-328

Informa Healthcare

Access to resources Recommend Favorite

Aging: Functional Metabolic Balance among cAMP, cGMP and Reactive Oxygen Intermediate Generation by Human Granulocytes

By  

Gerontology, Vol. 51, Iss. 6, 2005-11 ,pp. : 363-368

Karger

Access to resources Recommend Favorite